Clinical Trial
Fluocinonide compared with betamethasone in the treatment of eczema and psoriasis
- PMID: 781661
Item in Clipboard
Clinical Trial
Fluocinonide compared with betamethasone in the treatment of eczema and psoriasis
Practitioner.
1976 Jun.
Abstract
Good results have been obtained with a single daily application of fluocinonide ('Metosyn') to one area as compared with a twic-daily application of betamethasone 17-valerate ('Betnovate') to a similar area on the opposite side in the treatment of eczema and psoriasis. These conditions are difficult to control even in favourable circumstances and have a tendency to relapse despite any form of treatment. Both creams were entirely acceptable to the patients involved and during the course of the trial no patient expressed dissatisfaction with either the mode of treatment or the preparation involved.
Similar articles
-
Betamethasone valerate ointment compared with fluocinonide FAPG.Arch Dermatol. 1977 May;113(5):599-601. Arch Dermatol. 1977. PMID: 856049 Clinical Trial.
-
Comparative double-blind clinical trial of fluocinonide and betamethasone valerate.Acta Derm Venereol Suppl (Stockh). 1971 May;52(67):70-1. Acta Derm Venereol Suppl (Stockh). 1971. PMID: 4947904 Clinical Trial. No abstract available.
-
Clobetasol propionate versus fluocinonide creams in psoriasis and eczema.Int J Dermatol. 1985 Sep;24(7):461-5. doi: 10.1111/j.1365-4362.1985.tb05821.x. Int J Dermatol. 1985. PMID: 3902682 Clinical Trial.
-
[A double-blind clinical trial of fluocinonide and betamethasone valerate in psoriasis].Harefuah. 1974 Jul 15;87(2):59-60. Harefuah. 1974. PMID: 4605470 Clinical Trial. Hebrew. No abstract available.
-
Comparison of fluocinonide and betamethasone in the treatment of psoriasis and eczema.Acta Derm Venereol Suppl (Stockh). 1971 May;52(67):72-3. Acta Derm Venereol Suppl (Stockh). 1971. PMID: 5291636 Clinical Trial. No abstract available.
Cited by
-
Strategies for using topical corticosteroids in children and adults with eczema.Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013356. doi: 10.1002/14651858.CD013356.pub2. Cochrane Database Syst Rev. 2022. PMID: 35275399 Free PMC article.